J

John Wiley & Sons

Publishes scientific, technical, and medical literature

Overview

John Wiley & Sons publishes scholarly, professional, and educational content across science, technology, medicine, and the humanities. Its products include textbooks, journals, reference works, and digital resources delivered through the Wiley Online Library and other platforms. Wiley works with authors, editors, and peer reviewers to produce content, then distributes it via print, digital subscriptions, licensing, and open-access options to libraries, universities, researchers, and professionals. The company differentiates itself through a long history as a family-run business spanning six generations, a strategic shift from general printing to science and professional publishing, and a global scale as a publicly traded leader in educational and professional resources. Its goal is to provide reliable, accessible resources that support education, research, and professional development worldwide.

Work here?Claim your company

About John Wiley & Sons

Simplify's Rating
Why John Wiley & Sons is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

EducationHealthcare

Company Size

51-200

Company Stage

IPO

Headquarters

Hoboken, NJ

Founded

1807

Get referred to John Wiley & Sons

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Wiley booked $14 million AI revenue in Q1 fiscal 2027, with $50 million targeted.
  • Submissions rose 31% and customer retention stayed above 99% after the 2026 renewal season.
  • CAUL, CCS, and Liverpool University Press expanded 2026 partnerships, deepening recurring publishing reach.

What critics are saying

  • Learning revenue fell 20% in Q1 fiscal 2027, crushing margins and cash generation.
  • Emerald integration lifted debt to 2.7x EBITDA, raising refinancing pressure through 2027.
  • AI licensing is lumpy; $29 million prior-year comparison exposed fragile revenue dependence.

What makes John Wiley & Sons unique

  • Wiley owns 125-plus transformational agreements across 45 countries, embedding recurring scholarly access.
  • Research Exchange and Genesis Mission make Wiley infrastructure for trusted AI science workflows.
  • Emerald adds economics, business, and finance content, broadening Research's proprietary data moat.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$230k

Above

Industry Average

Funded Over

1 Rounds

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Equity Funding Comparison Coming Soon

Benefits

  • Remote Work Options
  • Hybrid Work Options
  • Professional Development Budget

Stock Price

Company News

MarketScreener
Oct 29th, 2026
John Wiley & Sons: Wiley's Advanced Portfolio to amplify breakthrough research across oncology, Immunology and Aging at 2026 Allison Institute symposium.

John Wiley & Sons: Wiley's Advanced Portfolio to amplify breakthrough research across oncology, Immunology and Aging at 2026 Allison Institute symposium. Published on 10/29/2026 at 11:11 am EDT UT MD Anderson symposium will convene more than 1,500 leading scientists, clinicians, researchers, and innovators to share discoveries, foster collaboration and advance the frontiers of science. Hoboken, NJ - Wiley's Advanced Portfolio will support scientific exchange and amplify breakthrough research from leading scientists and clinicians in immunology, cancer biology and human health at the 2026 James P. Allison Institute scientific symposium at The University of Texas MD Anderson Cancer Center in Houston, Texas. Following the theme "Immune Set Points: Stress, Wellness, and System Control," the symposium-taking place on October 30, 2026 at the TMC3 Collaborative Building in the Texas Medical Center's Helix Park-will convene more than 1,500 leading scientists, clinicians, journal editors, research trainees and innovators at the forefront of cancer immunology and immunotherapy research. Their purpose is to share groundbreaking discoveries, foster collaboration, and advance the frontiers of science. "The Allison Institute scientific symposium represents the kind of interdisciplinary scientific exchange that is essential to advancing our understanding of cancer and human health," said Allyn Molina, group vice president of publishing development at Wiley. "This symposium offers an amazing opportunity to connect research communities and drive forward ideas that can shape the future of health and medicine. Wiley is proud to support this community and the next generation of discoveries." The Allison Institute was established at UT MD Anderson to advance exceptional discovery, translational and clinical research that integrates immunobiology across disciplines. The institute builds on the legacy of its namesake, James P. Allison, Ph.D. who was awarded the 2018 Nobel Prize in Physiology or Medicine for fundamental discoveries in T cell biology that led to the invention of ipilimumab, the first immune checkpoint inhibitor to treat cancer. These discoveries helped to launch the field of cancer immunotherapy. The 2026 program features a plenary keynote from Nobel laureate William G. Kaelin Jr., M.D., scientific sessions across three tracks, a trainee poster session, and a panel featuring six Nobel laureates moderated by TIME Senior Health Correspondent Alice Park. This symposium coincides with the continuing expansion of Wiley's Advanced Portfolio into life and health sciences, including the recent launches of new journals Advanced Oncology, Advanced Immunology, and Advanced Healthy Aging, disciplines which are central to the symposium's scientific focus. At the symposium, the Advanced Portfolio will bring its commitment to publishing top-tier science into the room, including: * Supporting a dedicated dinner with a guest speaker, bringing the community together for deeper discussion; * Fostering awards to recognize emerging scientific talent and honor the rigorous, high-impact research the Advanced journals exist to publish; * Supporting an on-site podcast series to carry that same standard into conversation, with leading researchers exploring key themes from the presentations, emerging trends in oncology, immunology and human health, and the scientific questions shaping the next generation of discovery. To explore the Advanced Portfolio, visit: advanced.onlinelibrary.wiley.com. About Wiley Wiley (NYSE: WLY) is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact-Wiley is redefining what's possible in science and learning. Visit us atWiley.com andInvestors.Wiley.com. Follow us onFacebook,X,LinkedIn andInstagram. Attachments * Original document * Permalink Disclaimer John Wiley & Sons Inc. published this content on October 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 29, 2026 at 15:10 UTC. (C) Publicnow - 2026

Radical AI
Oct 26th, 2026
Wiley partners with Radical AI to superpower materials scientists.

Wiley partners with Radical AI to superpower materials scientists. High-quality data is a foundation for rigorous experimentation in the first AI-powered self-driving lab. Radical AI's self-driving labs are enabling a new speed of science, but doing so in deep collaboration with the institutions that shaped the field, from national laboratories to top academic and scholarly publishers. One such partnership is with the academic publisher Wiley. Radical AI references hundreds of thousands of papers every time it generates hypotheses for novel materials that are then synthesized and studied in the self-driving lab. A substantial portion of those are sourced via a collaboration with Wiley. Building the future - with strong foundations. As AI becomes more deeply integrated into scientific research, the quality and provenance of information have become increasingly important. Researchers need confidence that AI-generated outputs can be connected back to credible evidence and that recommendations are grounded in transparent, verifiable sources. Radical addresses this in two ways: First by referencing literature and experimental data, then by testing the most promising hypotheses in its self-driving lab. When a materials scientist inputs their target performance qualities, the long-horizon agent taps Wiley papers (as well as those from other academic publishers and open-source providers) for Retrieval-Augmented Generation (RAG), referencing relevant papers and documents to understand what has been done before and which novel compositions might be most promising. The system also references 70 million data points already generated from synthesis and characterization in the self-driving lab. Then, most crucially, the self-driving lab tests those AI-generated hypotheses through real synthesis and characterization. As candidate materials move through the lab, automated stations record data spanning composition, processing conditions, crystal structure, microstructure, density, hardness, stiffness, oxidation resistance, and more. This all feeds back into the AI to further fuel fast discoveries. Driving real results, faster. The process is working today: In initial campaigns aimed at discovering new materials to better serve the demands of hypersonic applications, Radical generated 300+ novel materials and outperformed the current industry-leading material in 16 weeks. As a point of comparison, the entire field has only experimentally studied 3,493 unique alloys in this space over 20+ years. See the case study Radical AI, Inc. published with Wiley here.

Robotics Tomorrow
Oct 13th, 2026
The Humanoid Economy by Modar Alaoui published today by Wiley.

The Humanoid Economy by Modar Alaoui published today by Wiley. New book lays out the path from technological promise of humanoid robots to transformative industry he Humanoid Economy: What Physical AI Means for Investment, Industry, and the Future of Work, a new book by Silicon Valley investor and Humanoids Summit founder Modar Alaoui, is published today by Wiley. More headlines. Articles. The Humanoid Economy is available from all leading book retailers, with more information at https://www.thehumanoideconomy.com/. "The next phase of the humanoid economy is less about what a robot can do once for a camera, and more about what it can do every day for a business," said Alaoui. "Getting there will require more than better robots. It will require the manufacturing, capital, infrastructure, policy and public acceptance to deploy them at scale. The humanoid race won't be won by whoever builds the best demo, but by whoever builds the best ecosystem." The book examines humanoid robotics not simply as a new category of machines, but as the foundation of a broader economic system emerging around physical AI. As humanoids move from laboratories and demonstrations into factories and other real-world environments, they are beginning to intersect simultaneously with labor, artificial intelligence, manufacturing, capital, safety, public policy, culture and geopolitics. Alaoui argues that all of those systems will have to evolve alongside the technology if humanoids are ever to reach their potential. Across seven chapters, The Humanoid Economy looks beyond the robots themselves to the forces that will determine whether humanoids become a transformative industry or remain a technological promise. Alaoui examines some of the conventional wisdom surrounding humanoids; including how they should be funded, what widespread adoption will actually require, and why fears about replacing human workers are "structurally implausible." He also examines why some of the most important signals of progress may have little to do with headline-grabbing demonstrations. "Humanoids will scale like an industrial technology, not a consumer app," adds Alaoui. "I expect humanoids to scale more like the telephone than the iPhone." Robotics Leaders on The Humanoid Economy The book has received endorsements from leaders spanning humanoid robotics, research, automation, and commercialization. Hiroshi Ishiguro, director of the Intelligent Robotics Laboratory and professor at Osaka University, says the book brings together the technological, economic and societal forces behind humanoid robotics and provides "an important perspective on where the field is headed." Jeff Burnstein, president of the Association for Advancing Automation (A3), calls the book a look at "a pivotal moment in robotics," bringing together advances in AI, hardware, standards and deployment. Luis Sentis, professor at The University of Texas at Austin and co-founder of Apptronik, says Alaoui frames humanoids not as replacements for people, but as technology that can "unlock new possibilities" and "amplify human labor." Joyce Sidopoulos, co-founder and chief of operations at MassRobotics, says the next wave of industrial investment will require more than hardware, highlighting the importance of "capital, standards, and trust" in allowing humanoids to operate safely around people. Werner Kraus, head of robotics at Fraunhofer IPA, says the book demonstrates why humanoid robotics represents "far more than another generation of industrial automation," examining the technologies, markets and ecosystem moving humanoids into real-world use. From Robots to Infrastructure Long-term estimates for the humanoid robotics industry vary widely, with projections cited by Morgan Stanley Research projecting that the market could surpass $5 trillion by 2050. Rather than assuming such forecasts are inevitable, The Humanoid Economy examines what would actually have to happen for the industry to approach that scale. That includes manufacturing capacity and supply chains; new approaches to financing hardware-intensive companies; safety standards and regulation; workforce preparation; business models capable of supporting fleets of machines; and public willingness to share workplaces and eventually other human environments with humanoid robots. "Once that transition occurs, humanoids stop being discussed as technology and start being discussed as infrastructure," Alaoui writes. An Investor's View from the Inside Alaoui is founder and general partner of ALM Ventures and founder and chair of Humanoids Summit, which brings together robotics companies, investors, researchers, manufacturers and policymakers. He also founded the Bay Area Robotics Association and created International Humanoids Day. In The Humanoid Economy, Alaoui draws on that experience to examine why the humanoid form factor is attracting significant investment, why physical AI presents different economic challenges from software AI, and how competition among the United States, China and other nations is turning humanoid robotics into a strategic industrial issue. The Humanoid Economy is written for investors, business leaders, robotics founders, policymakers, and others trying to understand not simply where humanoid technology is going, but what will have to develop around it. Publication Events Alaoui will mark the publication of The Humanoid Economy with a book signing and fireside chat in San Francisco on October 13, followed by another fireside chat and book signing at MassRobotics in Boston on October 15. About the Book: The Humanoid Economy: What Physical AI Means for Investment, Industry, and the Future of Work by Modar Alaoui (Wiley, October 2026). ISBN: 978-1-394-45364-1. For more information, please visit https://www.thehumanoideconomy.com/.

Specialty Soya and Grains Alliance
Sep 23rd, 2026
Wiley and the Canadian Cardiovascular Society partner to deliver leading cardiovascular journals.

Wiley and the Canadian Cardiovascular Society partner to deliver leading cardiovascular journals. Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced a new publishing partnership with the Canadian Cardiovascular Society (CCS), the national voice for cardiovascular clinicians and scientists in Canada. Founded in 1947, the CCS develops clinical practice guidelines, advances research, and shapes healthcare policy across Canada and beyond. Effective January 2027, Wiley will publish the Society's full journal portfolio: Canadian Journal of Cardiology, CCS's flagship hybrid title; and two gold open access journals, CJC Open and CJC Pediatric & Congenital Heart Disease. This leading cardiovascular portfolio gives researchers, clinicians, and policymakers across Canada and around the world continued access to rigorous, peer-reviewed research alongside Wiley's global publishing technology, editorial infrastructure, and distribution network. "Cardiovascular disease remains one of the most pressing challenges in global health, and the CCS has spent decades building and disseminating the evidence that guides how it's diagnosed and treated," said Jessica Kowalski, Wiley EVP & GM, Research. "We're proud to support the CCS's mission and help extend the reach of its research to clinicians, researchers, and health systems worldwide." "The CCS welcomes this new publishing partnership, which reflects our shared commitment to advancing cardiovascular science, supporting clinicians and researchers, and delivering trusted, high-quality content to our members and the broader medical community," said Dr. Sean Virani, President of the CCS Board of Directors. The partnership adds a respected clinical program to Wiley's health sciences portfolio. As the world's leading society publisher, this agreement reflects the company's ongoing commitment to supporting societies as they grow their research impact through open access publishing, global distribution, and emerging technologies. The CCS's journals are expected to be live on Wiley Online Library beginning January 2027. Member News Release submitted by Wiley on 09/17/2026. Sep 23, 2026

Electronics Weekly
Sep 15th, 2026
Gadget book: Artificial Intelligence (AI) zyBook.

Gadget book: Artificial Intelligence (AI) zyBook. This may be of interest: Wiley has introduced a new Artificial Intelligence (AI) zyBook for students to learn how to build AI systems. Designed to be interactive courseware for college-level AI courses (so it is aimed at instructors), the material is intended to cover more than foundational concepts. According to... Don't miss out on EW Newsletters. Get its news, blogs and comments straight to your inbox! Sign up for the Electronics Weekly newsletters: Mannerisms, Gadget Master and the Daily and Weekly roundups. Tune into EW's CHIIPS Podcast. The excellent Electronics Weekly podcast, CHIIPS, is brought to you by its editor Caroline Hayes. Hear interesting insights from a range of industry figures. Catch all the episodes" * Latest * Comments 15th September 2026 Electronics Weekly @ 65! Read its special features celebrating 65 years of Electronics Weekly and looking ahead to the future of the industry. Read the Electronics Weekly @ 65 features " Read the first ever Electronics Weekly online: 7th September 1960. Electronics Weekly has scanned the very first edition so you can enjoy it. Read the very first edition" Work break.

Recently Posted Jobs

Sign up to get curated job recommendations

John Wiley & Sons is Hiring for 71 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs